Printer Friendly

American Residential Properties Announces Cash Dividend.

SCOTTSDALE, Ariz., Sept. 28, 2015 /PRNewswire/ -- American Residential Properties, Inc. (NYSE: ARPI) (the "Company") today announced that, on September 25, 2015, its Board of Directors declared a dividend of $0.10 per share on the Company's outstanding shares of common stock. The dividend will be payable in cash on October 15, 2015 to stockholders of record at the close of business on October 7, 2015.

About American Residential Properties, Inc. American Residential Properties, Inc. is an internally managed real estate company, organized as a REIT for federal income tax purposes, that acquires, owns and manages single-family homes as rental properties in select communities nationwide. The Company's primary business strategy is to acquire, restore, lease and manage single-family homes as well-maintained investment properties to generate attractive, risk-adjusted returns over the long-term. With a vertically integrated real estate acquisition and management platform incorporating disciplined acquisition criteria, extensive research, seasoned personnel and comprehensive operations, the Company is well-positioned to execute its strategy.

Additional information about American Residential Properties, Inc. can be found on the Company's website at www.amresprop.com.

To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/american-residential-properties-announces-cash-dividend-300149637.html

SOURCE American Residential Properties, Inc.

COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 28, 2015
Words:271
Previous Article:JinkoSolar Supplies 49.8 MW of PV Modules for Mexico's Largest PV Plant.
Next Article:Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters